🎉 M&A multiples are live!
Check it out!

Applied BioCode Valuation Multiples

Discover revenue and EBITDA valuation multiples for Applied BioCode and similar public comparables like Healius, Cyclopharm, and CurveBeam AI.

Applied BioCode Overview

About Applied BioCode

Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.


Founded

2016

HQ

Taiwan
Employees

n/a

Website

apbiocode.com

Financials

Last FY Revenue $11.4M

Last FY EBITDA -$6.6M

EV

$47.3M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Applied BioCode Financials

In the most recent fiscal year, Applied BioCode achieved revenue of $11.4M and an EBITDA of -$6.6M.

Applied BioCode expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Applied BioCode valuation multiples based on analyst estimates

Applied BioCode P&L

NTM Last FY FY 2025 FY 2026 FY 2027
Revenue XXX $11.4M XXX XXX XXX
Gross Profit XXX $6.8M XXX XXX XXX
Gross Margin XXX 59% XXX XXX XXX
EBITDA XXX -$6.6M XXX XXX XXX
EBITDA Margin XXX -58% XXX XXX XXX
EBIT XXX -$9.3M XXX XXX XXX
EBIT Margin XXX -81% XXX XXX XXX
Net Profit XXX -$8.7M XXX XXX XXX
Net Margin XXX -76% XXX XXX XXX
Net Debt XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Applied BioCode Stock Performance

As of May 30, 2025, Applied BioCode's stock price is TWD 21 (or $1).

Applied BioCode has current market cap of TWD 2.2B (or $73.0M), and EV of TWD 1.4B (or $47.3M).

See Applied BioCode trading valuation data

Applied BioCode Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$47.3M $73.0M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Applied BioCode Valuation Multiples

As of May 30, 2025, Applied BioCode has market cap of $73.0M and EV of $47.3M.

Applied BioCode's trades at 4.1x EV/Revenue multiple, and -7.2x EV/EBITDA.

Equity research analysts estimate Applied BioCode's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Applied BioCode's P/E ratio is not available.

See valuation multiples for Applied BioCode and 12K+ public comps

Applied BioCode Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $73.0M XXX $73.0M XXX XXX XXX
EV (current) $47.3M XXX $47.3M XXX XXX XXX
EV/Revenue n/a XXX 4.1x XXX XXX XXX
EV/EBITDA n/a XXX -7.2x XXX XXX XXX
EV/EBIT n/a XXX -5.1x XXX XXX XXX
EV/Gross Profit n/a XXX n/a XXX XXX XXX
P/E n/a XXX -8.4x XXX XXX XXX
EV/FCF n/a XXX -6.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Applied BioCode Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Applied BioCode Margins & Growth Rates

Applied BioCode's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Applied BioCode's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Applied BioCode's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Applied BioCode and other 12K+ public comps

Applied BioCode Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth n/a XXX n/a XXX XXX XXX
EBITDA Margin n/a XXX -58% XXX XXX XXX
EBITDA Growth n/a XXX n/a XXX XXX XXX
Rule of 40 n/a XXX n/a XXX XXX XXX
Bessemer Rule of X XXX XXX n/a XXX XXX XXX
Revenue per Employee XXX XXX n/a XXX XXX XXX
Opex per Employee XXX XXX n/a XXX XXX XXX
S&M Expenses to Revenue XXX XXX 27% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 79% XXX XXX XXX
Opex to Revenue XXX XXX 140% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Applied BioCode Public Comps

See public comps and valuation multiples for Medical Imaging & Diagnostics and Laboratory Services comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Australian Clinical Labs XXX XXX XXX XXX XXX XXX
Clarity Pharmaceuticals XXX XXX XXX XXX XXX XXX
CurveBeam AI XXX XXX XXX XXX XXX XXX
Cyclopharm XXX XXX XXX XXX XXX XXX
Healius XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Applied BioCode M&A and Investment Activity

Applied BioCode acquired  XXX companies to date.

Last acquisition by Applied BioCode was  XXXXXXXX, XXXXX XXXXX XXXXXX . Applied BioCode acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Applied BioCode

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About Applied BioCode

When was Applied BioCode founded? Applied BioCode was founded in 2016.
Where is Applied BioCode headquartered? Applied BioCode is headquartered in Taiwan.
Is Applied BioCode publicy listed? Yes, Applied BioCode is a public company listed on TAI.
What is the stock symbol of Applied BioCode? Applied BioCode trades under 6598 ticker.
When did Applied BioCode go public? Applied BioCode went public in 2017.
Who are competitors of Applied BioCode? Similar companies to Applied BioCode include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm.
What is the current market cap of Applied BioCode? Applied BioCode's current market cap is $73.0M
Is Applied BioCode profitable? Yes, Applied BioCode is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.